Acquiring an established urgent care clinic offers immediate cash flow, existing payer contracts, and a credentialed provider team — but de novo development gives you control over location, brand, and clinical model. Here's how to decide.
The urgent care sector is one of the most acquisition-friendly spaces in lower middle market healthcare. With over 11,000 clinics operating across a highly fragmented U.S. market and valuations typically ranging from 3.5x to 6x EBITDA, the buy-vs-build question is genuinely consequential for investors. Acquiring an existing clinic means stepping into operational infrastructure — payer contracts, trained staff, credentialed physicians, and a patient base — that can take three to five years to replicate organically. Building from scratch, however, allows a buyer to select the ideal trade area, design workflows from day one, avoid inheriting prior billing compliance issues, and potentially enter markets where no quality clinic is currently for sale. The right answer depends heavily on your timeline, capital structure, regulatory tolerance, and whether you're a first-time healthcare operator or an experienced platform buyer executing a roll-up strategy.
Find Urgent Care Clinic Businesses to AcquireAcquiring an established urgent care clinic allows you to bypass the most time-intensive and highest-risk phases of clinic development — provider credentialing, payer contracting, and brand building. A clinic generating $1M–$5M in annual revenue with a 15–25% EBITDA margin and a diversified payer mix is a cash-flowing asset from day one, often financeable with an SBA 7(a) loan covering 80–90% of the purchase price.
Private equity-backed healthcare platforms executing roll-up strategies, regional urgent care chains seeking geographic expansion, hospital systems pursuing outpatient access points, and entrepreneurial operators with healthcare backgrounds who want immediate cash flow and a proven clinical operation rather than a startup risk profile.
Opening a de novo urgent care clinic gives investors complete control over site selection, brand positioning, clinical model design, and staffing culture. However, it requires significant upfront capital, a 12–24 month pre-revenue development timeline, and the patience to build payer contract relationships and provider credentialing from scratch — all while absorbing operating losses during the ramp-up phase.
Well-capitalized healthcare platforms with existing operational infrastructure (credentialing teams, payer relationships, EHR systems) who are entering underserved markets with no viable acquisition targets, or experienced urgent care operators expanding organically from a strong existing footprint who can leverage shared services to compress the development timeline.
For most lower middle market investors entering or expanding in urgent care, acquisition is the superior path. The value of an established urgent care clinic is not simply its revenue — it is the three to five years of operational infrastructure embedded in payer contracts, credentialed providers, community brand recognition, and employer relationships that cannot be shortcut. De novo development makes strategic sense only for platforms that already operate urgent care clinics and can leverage shared credentialing, payer relationships, and management infrastructure to compress the startup timeline — or for investors entering genuinely underserved markets where no acquisition-ready clinic exists. For first-time healthcare operators or investors deploying SBA capital, acquiring a proven clinic with clean financials, a diversified commercial payer mix, and a provider team not dependent on the exiting owner delivers the most reliable path to cash-on-cash returns in this sector.
Do you have 12–24 months and $300K–$600K in working capital reserves to absorb operating losses during a de novo ramp-up, or do you need a cash-flowing asset from day one to service acquisition debt?
Are there established urgent care clinics with $1M–$5M in revenue, clean billing compliance histories, and diversified payer mixes available for acquisition in your target market, or is the local market undersupplied with no viable targets?
Do you have existing payer contracting relationships, a credentialing infrastructure, and clinical recruiting capabilities that would allow you to compress the 18–36 month de novo development timeline, or would you be starting from zero?
Is the seller's clinical team credentialed, employed, and contractually retained beyond the closing date, or is the clinic heavily dependent on an owner-physician whose departure would eliminate a significant portion of patient volume?
Can the existing payer contracts — including commercial insurance, Medicare, workers' compensation, and employer occupational health agreements — be confirmed as assignable without triggering change-of-control renegotiation clauses that could materially reduce post-close reimbursement rates?
Browse Urgent Care Clinic Businesses For Sale
Skip the build phase — acquire existing customers, revenue, and cash flow from day one.
Acquisition costs for urgent care clinics generating $1M–$5M in annual revenue typically range from $1.75M to $6M, based on EBITDA multiples of 3.5x to 6x. With SBA 7(a) financing, buyers can often structure deals with 10–20% equity down, reducing the out-of-pocket requirement to $175K–$1.2M plus closing costs of $50K–$150K for legal, due diligence, and licensing transfer fees.
A de novo urgent care clinic typically requires 12–24 months from lease signing to full operational status with complete payer contracting. Payer credentialing alone takes 6–18 months, and patient volume ramp-up to stabilized EBITDA margins of 15–25% generally requires 24–36 months. Platforms with existing payer relationships and credentialing infrastructure can compress this timeline, but first-time operators should budget for a 2–3 year runway before achieving full profitability.
Yes, in most states non-physicians can own urgent care clinics through a Management Services Organization (MSO) structure, which separates the business management entity from the licensed medical practice. The MSO is owned by the investor and contracts with a physician-owned professional corporation (PC) to provide clinical services. This structure complies with corporate practice of medicine (CPOM) laws that prohibit direct non-physician ownership of medical practices in many states. Consulting a healthcare attorney familiar with CPOM regulations in your target state is essential before structuring any acquisition.
The most significant red flags include payer contracts with change-of-control clauses that could trigger renegotiation upon sale, high accounts receivable aging over 90 days indicating collections problems, heavy reliance on Medicaid or self-pay payers with low reimbursement rates, owner-physician performing the majority of clinical shifts with no succession plan, and unresolved billing compliance issues including prior OIG audit findings or claims denial rates above 10–15%. Each of these can materially impair post-close cash flow or create regulatory liability for the buyer.
Healthy urgent care clinics in the lower middle market typically operate at EBITDA margins of 15–25%. Margins below 10% may indicate revenue cycle inefficiencies, unfavorable payer mix, or excessive owner compensation that hasn't been normalized. Margins above 25% in a standalone clinic warrant scrutiny — they may reflect underinvestment in staffing, deferred capital expenditures, or an unusually favorable payer mix that may not be sustainable post-acquisition. Always normalize EBITDA for owner compensation, personal expenses, and non-recurring items before applying a purchase multiple.
Not automatically. Payer contracts — including agreements with commercial insurers, Medicare, Medicaid managed care, and workers' compensation carriers — must be reviewed individually for assignment and change-of-control provisions. Some contracts transfer with notification only, while others require formal consent or renegotiation upon a change in ownership or corporate structure. Payer contract transferability review is one of the most critical components of urgent care acquisition due diligence and should be completed by a healthcare attorney before closing.
More Urgent Care Clinic Guides
Get access to acquisition targets with real revenue, real customers, and real cash flow.
Create your free accountNo credit card required
For Buyers
For Sellers